Assessment of platelet numbers and morphology in the peripheral blood smear

Clinics in Laboratory Medicine

Volumn 22, Issue 1, 2002, Pages 193-213

  Moreno, Alvaro ^a   Menke, David ^b  

^a Division of Hematology/Oncology and Internal Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ALLOPURINOL; ALPRENOLOL; AMINOGLUTETHIMIDE; AMINOSALICYLIC ACID; AMIODARONE; AMITRIPTYLINE; AMPHOTERICIN B; AMPICILLIN; AMRINONE; ANTAZOLINE; CAPTOPRIL; CARBAMAZEPINE; CEFALEXIN; CEFALOTIN; CEFAMANDOLE; CEFOTETAN; CEFTAZIDIME; CHLOROTHIAZIDE; CHLORPHENIRAMINE; CHLORPROMAZINE; CHLORPROPAMIDE; CHLORTALIDONE; CIMETIDINE; CIPROFLOXACIN; DACTINOMYCIN; PARACETAMOL; UNINDEXED DRUG;

AUTOMATION; BLOOD SMEAR; CLINICAL FEATURE; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTE STRUCTURE; THROMBOCYTOPENIA; THROMBOCYTOSIS;

EID: 0036127268     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(03)00072-6     Document Type: Review

References (112)

1. Thrombocytopenia in von Willebrand's disease
2. Evidence for genetic homogeneity in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML)
3. Drug-induced immune thrombocytopenia: An overview of pathogenesis
4. Can drugs cause autoimmune thrombocytopenic purpura?
5. Alcohol-associated pancytopenia with hypocellular bone marrow
6. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection
7. High-dose intravenous immunoglobulin for post-transfusion purpura
8. Sur une nouvelle variete de dysthrophie thrombocytaire hemorrhagipare parse congenitale
9. Gray platelet syndrome in the elderly
10. Platelet function studies in the Bernard-Soulier syndrome
11. Platelet satellitosis to polymorphonuclears: Cytochemical, immunological and structural characterization of eight cases
12. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23
13. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: Ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors
14. Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin
15. Megakaryocytes and myelofibrosis in gray platelet syndrome
16. Italian Registry of Familial and Recurrent HUS/TTP. The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20
17. Advances in the diagnosis of idiopathic thrombocytopenic purpura
18. Post-transfusion purpura: Successful treatment by exchange transfusion
19. Molecular abnormalities in Glanzmann's thromboasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease
20. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high resolution two dimensional gel electrophoresis
21. Thrombocytopenia of severe alcoholism
22. Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: Mechanism of reactive thrombocytosis
23. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome
24. Adult idiopathic thrombocytopenic purpura: Clinical findings and response to therapy
25. X-linked thrombocytopenia due to a novel mutation of GATA-1
26. Hereditary macrothrombocytopathia, nephritis and deafness
27. Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis
28. Primary thrombocytopenic purpura and acquired hemolytic anemia
29. Pathophysiology of heparin-induced thrombocytopenia: Clinical and diagnostic implications-a review
30. Platelet characteristics in patients with X-linked macrothrombocytopenia due to a novel GATA-1 mutation
31. Physical, chemical and functional changes following platelet activation in normal and "giant" platelets
32. Von Willebrand factor-cleaving protease in thrombocytopenic purpura and the hemolytic uremic syndrome
33. Tirofiban and Eptifibatide, but not abciximab, induce leukocyte-platelet aggregation
34. Platelets: Acute thrombocytopenia
35. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults
36. Drug-induced thrombocytopenia: A systematic review of published case reports
37. Bernard-Soulier disease: A study of four patients and their parents
38. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
39. Assay of von Willebrand factor (vWF)cleaving protease based on decreased collagen binding affinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)
40. Management of idiopathic thrombocytopenic purpura in pregnancy
41. Drug-induced thrombocytopenia: Is it a serious concern for glycoprotein IIb/IIIa receptor inhibitors?
42. Thrombocytopenia with GP IIb/IIIa inhibitors: A meta-analysis
43. Haemorrhagic thrombocytopathy associated with dilatation of the platelet-membrane complex
44. Heparin-induced thrombocytopenia-pathogenesis and treatment
45. May-Hegglin anomaly: A rare cause of thrombocytopenia
46. Sebastian platelet syndrome: A new variant of hereditary macrothrombocytopenia with leukocyte inclusions
47. Platelet to leukocyte adherence phenomena associated with thrombocytopenia
48. Static and functional morphology of the pathological platelets in myelofibrosis and myeloproliferative syndrome
49. Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2
50. Hereditary giant platelet syndrome: A new disorder of platelet function
51. The use of electron microscopy in the investigation of the ultrastructural morphology of immune thrombocytopenic purpura platelets
52. Gray platelet syndrome with splenomegaly and signs of extramedullary hematopoiesis: A case report with review of the literature
53. Autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly) is linked to chromosome 22q12-13
54. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly
55. Gray platelet syndrome: Selective alphagranule deficiency and thrombocytopenia due to increased platelet turnover
56. Partial clinical improvement in Upshaw-Schulman syndrome following prostacyclin infusion
57. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome)
58. Mapping of a gene for May-Hegglin anomaly to chromosome 22q
59. Acute idiopathic thrombocytopenic purpura presenting a high serum level of immunoglobulin E and eosinophilia in an elderly patient
60. IIB von Willebrand's disease: Pathogenetic and therapeutic studies
61. Post-transfusion purpura treated with plasma exchange by Haemonetics Cell Separator
62. Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid
63. Effect of ethanol on thrombopoiesis
64. Thrombocytopenia caused by immunologic platelet destruction
65. Gray platelet syndrome: Alpha-granule deficiency. Its influence on platelet function
66. Bernard-Soulier syndrome
67. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome
68. The May-Hegglin anomaly: Platelet function, ultrastructure and chromosome studies
69. Gray platelet syndrome
70. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative disease
71. Hemostasis testing during massive blood replacement: A study of 172 cases
72. Fechtner syndrome: Physiologic analysis of macrothrombocytopenia
73. Refractory thrombocytopenia: A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura
74. Shape-changing agents produce abnormally large platelets in a hereditary "giant platelets syndrome (MPS)"
75. Images in cardiovascular medicine: Pseudothrombocytopenia after abciximab (Reopro) treatment
76. Diagnosis of Bernard-Soulier syndrome and Glanzmann's thromboasthenia with a monoclonal assay in whole blood
77. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes: The May-Hegglin/Fechtner Syndrome Consortium
78. Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome
79. Preeclampsia effect on platelet count
80. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA 1
81. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura
82. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): Clinical and laboratory findings
83. The analytical basis for the use of platelet estimates from peripheral blood smears
84. Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease
85. The Wiskott-Aldrich syndrome
86. Wiskott-Aldrich syndrome protein and platelets
87. Montreal platelet syndrome: A defect in calcium-activated neutral proteinase (calpain)
88. Fechtner syndrome: A variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia
89. Gray platelet syndrome: A variety of qualitative platelet disorder
90. Thrombotic thrombocytopenia purpura: Report of 25 cases and a review of the literature
91. Drug-induced thrombocytopenia
92. Upshaw-Schulman syndrome in two siblings
93. Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome
94. Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): A study of 118 cases
95. Megakaryocytes and platelets in alpha-granule disorders
96. Thrombasthenic-thrombopathic thrombocytopenia with giant, "Swiss-cheese" platelets: A case report
97. Haploinsufficiency of CBFA 2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia
98. Disseminated intravascular coagulation: Findings in 346 patients
99. Recent advances in our understanding of Wiskott-Aldrich syndrome
100. Suppression of hematopoiesis by ethanol
101. Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis
102. Bernard-Soulier syndrome: Quantitative characterization of megakaryocytes and platelets by flow cytometry and platelet kinetic measurements
103. Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13
104. Autosomal-dominant giant platelet syndromes: A hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13
105. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes and low platelet in severe preeclampsia
106. Longitudinal analysis of platelet count and volume in normal pregnancy
107. Post-transfusion purpura: A report of five cases and review of the pathogenesis and management
108. Heparin-induced thrombocytopenia: A ten-year retrospective
109. Thrombocytopenia due to platelet destruction and hypersplenism
110. Structural characterization and chromosomal location of the gene encoding human platelet glycoprotein Ib beta
111. Increased serum level of interleukin-6 in patients with psoriatic arthritis and thrombocytosis
112. Thrombocytopenia induced by human parvovirus B19 infections